Differentiation-dependent changes in levels of C/EBPβ repressors and activators regulate human papillomavirus type 31 late gene expression

Journal of Virology

Volumn 86, Issue 9, 2012, Pages 5393-5398

  Gunasekharan, Vignesh ^a   Haché, Guylaine ^a   Laimins, Laimonis ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BASIC LEUCINE ZIPPER TRANSCRIPTION FACTOR; BINDING PROTEIN; CCAAT ENHANCER BINDING PROTEIN BETA; ISOPROTEIN; TRANSCRIPTION FACTOR;

AMINO TERMINAL SEQUENCE; ARTICLE; CELL CYCLE G2 PHASE; CELL CYCLE M PHASE; CELL DIFFERENTIATION; CELL GROWTH; CODON; EPISOME; GENE ACTIVATION; GENE EXPRESSION; HUMAN PAPILLOMAVIRUS TYPE 31; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN BINDING; PROTEIN DOMAIN; PROTEIN EXPRESSION; REPRESSOR GENE; VIRUS GENOME;

BASE SEQUENCE; BINDING SITES; CCAAT-ENHANCER-BINDING PROTEIN-BETA; CELL DIFFERENTIATION; CELL LINE; GENE EXPRESSION REGULATION, VIRAL; GENE SILENCING; HUMAN PAPILLOMAVIRUS 31; HUMANS; KERATINOCYTES; MUTAGENESIS, SITE-DIRECTED; PROMOTER REGIONS, GENETIC; PROTEIN ISOFORMS; RESPONSE ELEMENTS; TRANSCRIPTION, GENETIC;

HUMAN PAPILLOMAVIRUS; HUMAN PAPILLOMAVIRUS TYPE 31;

EID: 84861309070     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.07239-11     Document Type: Article

References (33)

1. Apt D, Watts RM, Suske G, Bernard HU. 1996. High Sp1/Sp3 ratios in epithelial cells during epithelial differentiation and cellular transformation correlate with the activation of the HPV-16 promoter. Virology 224: 281-291.
2. Baer M, Johnson PF. 2000. Generation of truncated C/EBPbeta isoforms by in vitro proteolysis. J. Biol. Chem. 275:26582-26590.
3. Baldwin BR, Timchenko NA, Zahnow CA. 2004. Epidermal growth factor receptor stimulation activates the RNA binding protein CUG-BP1 and increases expression of C/EBPbeta-LIP in mammary epithelial cells. Mol. Cell. Biol. 24:3682-3691.
4. Bodily JM, Mehta KP, Cruz L, Meyers C, Laimins LA. 2011. The E7 open reading frame acts in cis and in trans to mediate differentiation-dependent activities in the human papillomavirus type 16 life cycle. J. Virol. 85:8852-8862.
5. Bodily JM, Meyers C. 2005. Genetic analysis of the human papillomavirus type 31 differentiation-dependent late promoter. J. Virol. 79:3309-3321.
6. Butz K, Hoppe-Seyler F. 1993. Transcriptional control of human papillomavirus (HPV) oncogene expression: composition of the HPV type 18 upstream regulatory region. J. Virol. 67:6476-6486.
7. Calkhoven CF, Muller C, Leutz A. 2000. Translational control of C/EBPalpha and C/EBPbeta isoform expression. Genes Dev. 14:1920-1932.
8. Chong T, Chan WK, Bernard HU. 1990. Transcriptional activation of human papillomavirus 16 by nuclear factor I, AP1, steroid receptors and a possibly novel transcription factor, PVF: a model for the composition of genital papillomavirus enhancers. Nucleic Acids Res. 18:465-470.
9. Cripe TP, et al. 1990. Transcriptional activation of the human papillomavirus-16 P97 promoter by an 88-nucleotide enhancer containing distinct cell-dependent and AP-1-responsive modules. New Biol. 2:450-463.
10. del Mar Peña LM, Laimins LA. 2001. Differentiation-dependent chromatin rearrangement coincides with activation of human papillomavirus type 31 late gene expression. J. Virol. 75:10005-10013.
11. Demeret C, Desaintes C, Yaniv M, Thierry F. 1997. Different mechanisms contribute to the E2-mediated transcriptional repression of human papillomavirus type 18 viral oncogenes. J. Virol. 71:9343-9349.
12. Descombes P, Schibler U. 1991. A liver-enriched transcriptional activator protein, LAP, and a transcriptional inhibitory protein, LIP, are translated from the same mRNA. Cell 67:569-579.
13. Fehrmann F, Klumpp DJ, Laimins LA. 2003. Human papillomavirus type 31 E5 protein supports cell cycle progression and activates late viral functions upon epithelial differentiation. J. Virol. 77:2819-2831.
14. Frattini MG, Lim HB, Laimins LA. 1996. In vitro synthesis of oncogenic human papillomaviruses requires episomal genomes for differentiationdependent late expression. Proc. Natl. Acad. Sci. U. S. A. 93:3062-3067.
15. Grassmann K, Rapp B, Maschek H, Petry KU, Iftner T. 1996. Identification of a differentiation-inducible promoter in the E7 open reading frame of human papillomavirus type 16 (HPV-16) in raft cultures of a new cell line containing high copy numbers of episomal HPV-16 DNA. J. Virol. 70:2339-2349.
16. Hubert WG, Kanaya T, Laimins LA. 1999. DNA replication of human papillomavirus type 31 is modulated by elements of the upstream regulatory region that lie 5= of the minimal origin. J. Virol. 73:1835-1845.
17. Hummel M, Hudson JB, Laimins LA. 1992. Differentiation-induced and constitutive transcription of human papillomavirus type 31b in cell lines containing viral episomes. J. Virol. 66:6070-6080.
18. Kanaya T, Kyo S, Laimins LA. 1997. The 5= region of the human papillomavirus type 31 upstream regulatory region acts as an enhancer which augments viral early expression through the action of YY1. Virology 237: 159-169.
19. Kukimoto I, Takeuchi T, Kanda T. 2006. CCAAT/enhancer binding protein beta binds to and activates the P670 promoter of human papillomavirus type 16. Virology 346:98-107.
20. Kyo S, et al. 1993. NF-IL6 represses early gene expression of human papillomavirus type 16 through binding to the noncoding region. J. Virol. 67:1058-1066.
21. Mighty KK, Laimins LA. 2011. p63 is necessary for the activation of human papillomavirus late viral functions upon epithelial differentiation. J. Virol. 85:8863-8869.
22. Moody CA, Laimins LA. 2010. Human papillomavirus oncoproteins: pathways to transformation. Nat. Rev. Cancer 10:550-560.
23. Moody CA, Laimins LA. 2009. Human papillomaviruses activate the ATM DNA damage pathway for viral genome amplification upon differentiation. PLoS Pathog. 5:e1000605.
24. Münger K, Howley PM. 2002. Human papillomavirus immortalization and transformation functions. Virus Res. 89:213-228.
25. Ozbun MA, Meyers C. 1997. Characterization of late gene transcripts expressed during vegetative replication of human papillomavirus type 31b. J. Virol. 71:5161-5172.
26. Ramji DP, Foka P. 2002. CCAAT/enhancer-binding proteins: structure, function and regulation. Biochem. J. 365(Pt. 3):561-575.
27. Ruesch MN, Laimins LA. 1998. Human papillomavirus oncoproteins alter differentiation-dependent cell cycle exit on suspension in semisolid medium. Virology 250:19-29.
28. Spink KM, Laimins LA. 2005. Induction of the human papillomavirus type 31 late promoter requires differentiation but not DNA amplification. J. Virol. 79:4918-4926.
29. Timchenko NA, Welm AL, Lu X, Timchenko LT. 1999. CUG repeat binding protein (CUGBP1) interacts with the 5= region of C/EBPbeta mRNA and regulates translation of C/EBPbeta isoforms. Nucleic Acids Res. 27:4517-4525.
30. Wang HK, Duffy AA, Broker TR, Chow LT. 2009. Robust production and passaging of infectious HPV in squamous epithelium of primary human keratinocytes. Genes Dev. 23:181-194.
31. Wong PP, Pickard A, McCance DJ. 2010. p300 alters keratinocyte cell growth and differentiation through regulation of p21(Waf1/CIP1). PLoS One 5:e8369.
32. Wooldridge TR, Laimins LA. 2008. Regulation of human papillomavirus type 31 gene expression during the differentiation-dependent life cycle through histone modifications and transcription factor binding. Virology 374:371-380.
33. Zahnow CA, Cardiff RD, Laucirica R, Medina D, Rosen JM. 2001. A role for CCAAT/enhancer binding protein beta-liver-enriched inhibitory protein in mammary epithelial cell proliferation. Cancer Res. 61:261-269.